| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $408.3M | +49.1% |
| Cost of Revenue | $169.6M | +52.2% |
| Gross Profit | $238.7M | +46.9% |
| R&D Expense | $121.6M | +53.2% |
| SG&A Expense | $83.5M | +16.7% |
| Operating Income | -$94.0M | -31.8% |
| Interest Expense | $2.8M | +85.4% |
| Pre-tax Income | -$97.8M | -32.2% |
| Income Tax | $4.1M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $82.0M | -6.8% |
| Accounts Receivable | $99.5M | +33.5% |
| Current Assets | $207.2M | +12.9% |
| Total Assets | $1.33B | +2.0% |
| Current Liabilities | $205.2M | +17.7% |
| Total Liabilities | $299.6M | +30.0% |
| Stockholders' Equity | $1.02B | -4.1% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.4M | +20.0% |
| Capital Expenditures | $18.3M | +235.7% |
| Investing Cash Flow | -$20.7M | +92.6% |
| Financing Cash Flow | $36.7M | +130.6% |
| Free Cash Flow | -$33.7M | -36.6% |
| +117.1% |
| Net Income | -$102.7M | -107.7% |
| EPS (Basic) | -$0.93 | -82.4% |
| EPS (Diluted) | -$0.93 | -82.4% |